Lee Si-Wook, Yoon Sung-Joon, Jung Ki-Jin, Yeo Eui-Dong, Won Sung-Hun, Hong Chang-Hwa, Wang Soon-Do, Cho Yong-Chan, Ji Jae-Young, Byeon Je-Yeon, Lee Dhong-Won, Kim Woo-Jong
Department of Orthopedic Surgery, Dongsan Medical Center, Keimyung University, Daegu 42601, Republic of Korea.
Department of Orthopaedic Surgery, Soonchunhyang University Hospital Cheonan, Cheonan 31151, Republic of Korea.
J Clin Med. 2025 Mar 24;14(7):2207. doi: 10.3390/jcm14072207.
Syndesmotic instability presents a significant challenge in orthopedic surgery, with no universally accepted treatment approach. Traditional methods, such as trans-syndesmotic screw fixation, remain widely used but are associated with complications, including malreduction, hardware-related issues, and restricted physiological motion. Recent advancements in flexible dynamic fixation, particularly suture tape augmentation, offer promising alternatives by preserving native biomechanics and enabling early rehabilitation. This technical note details an anterior-to-posterior syndesmotic augmentation technique using suture tape to address unstable syndesmotic injuries involving both the anterior inferior tibiofibular ligament and posterior inferior tibiofibular ligament. The proposed technique aims to restore stability, reduce complications, and improve functional outcomes. The technique eliminates the need for hardware removal, supports early weight-bearing, and minimizes postoperative limitations. Anterior-to-posterior syndesmotic augmentation with suture tape represents a viable alternative for syndesmotic instability. Further clinical and biomechanical studies are warranted to validate its long-term efficacy and applicability across diverse patient populations.
下胫腓联合不稳定在骨科手术中是一项重大挑战,目前尚无普遍接受的治疗方法。传统方法,如经下胫腓联合螺钉固定,仍被广泛使用,但存在并发症,包括复位不良、硬件相关问题以及生理活动受限。柔性动态固定的最新进展,特别是缝线带增强技术,通过保留自然生物力学并实现早期康复,提供了有前景的替代方案。本技术说明详细介绍了一种从前向后的下胫腓联合增强技术,使用缝线带处理涉及下胫腓前韧带和下胫腓后韧带的不稳定下胫腓联合损伤。所提出的技术旨在恢复稳定性、减少并发症并改善功能结果。该技术无需取出硬件,支持早期负重,并将术后限制降至最低。缝线带从前向后增强下胫腓联合是下胫腓联合不稳定的一种可行替代方案。有必要进行进一步的临床和生物力学研究,以验证其长期疗效以及在不同患者群体中的适用性。